173 related articles for article (PubMed ID: 33482834)
1. Protein liposomes-mediated targeted acetylcholinesterase gene delivery for effective liver cancer therapy.
Wang K; Shang F; Chen D; Cao T; Wang X; Jiao J; He S; Liang X
J Nanobiotechnology; 2021 Jan; 19(1):31. PubMed ID: 33482834
[TBL] [Abstract][Full Text] [Related]
2. [Preparation and gene expression of transferrin modified gene loaded procationic liposomes].
Zhong ZR; Liu J; Deng Y; Zhang ZR; Song QG; He Q
Yao Xue Xue Bao; 2007 Feb; 42(2):216-20. PubMed ID: 17518055
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
Zhang B; Zhang Y; Yu D
Oncol Rep; 2017 Feb; 37(2):937-944. PubMed ID: 27959442
[TBL] [Abstract][Full Text] [Related]
4. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo.
Wei Y; Gu X; Cheng L; Meng F; Storm G; Zhong Z
Acta Biomater; 2019 Jul; 92():196-204. PubMed ID: 31102765
[TBL] [Abstract][Full Text] [Related]
5. Complexes containing cationic and anionic pH-sensitive liposomes: comparative study of factors influencing plasmid DNA gene delivery to tumors.
Chen Y; Sun J; Lu Y; Tao C; Huang J; Zhang H; Yu Y; Zou H; Gao J; Zhong Y
Int J Nanomedicine; 2013; 8():1573-93. PubMed ID: 23637529
[TBL] [Abstract][Full Text] [Related]
6. Dual-Effect of Magnetic Resonance Imaging Reporter Gene in Diagnosis and Treatment of Hepatocellular Carcinoma.
Zhou J; Zhou Q; Shu G; Wang X; Lu Y; Chen H; Hu T; Cai J; Du Y; Yu R
Int J Nanomedicine; 2020; 15():7235-7249. PubMed ID: 33061378
[TBL] [Abstract][Full Text] [Related]
7. A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma-targeted drug delivery.
Tang J; Wang Q; Yu Q; Qiu Y; Mei L; Wan D; Wang X; Li M; He Q
Acta Biomater; 2019 Jan; 83():379-389. PubMed ID: 30395963
[TBL] [Abstract][Full Text] [Related]
8. Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv.
Xu L; Tang WH; Huang CC; Alexander W; Xiang LM; Pirollo KF; Rait A; Chang EH
Mol Med; 2001 Oct; 7(10):723-34. PubMed ID: 11713371
[TBL] [Abstract][Full Text] [Related]
9. Dual-Modified Liposome for Targeted and Enhanced Gene Delivery into Mice Brain.
Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
J Pharmacol Exp Ther; 2020 Sep; 374(3):354-365. PubMed ID: 32561686
[TBL] [Abstract][Full Text] [Related]
10. Oxygen nanocarrier broke the hypoxia trap of solid tumors and rescued transfection efficiency for gene therapy.
Qin B; Jiang M; Li X; Shi Y; Zhang J; Luo Z; Luo L; Lu Y; Liu X; Wang S; Du Y; Qiu Y; Lou Y; You J
J Nanobiotechnology; 2021 Dec; 19(1):427. PubMed ID: 34922537
[TBL] [Abstract][Full Text] [Related]
11. p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome.
Nakase M; Inui M; Okumura K; Kamei T; Nakamura S; Tagawa T
Mol Cancer Ther; 2005 Apr; 4(4):625-31. PubMed ID: 15827336
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
13. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
[TBL] [Abstract][Full Text] [Related]
14. Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties.
Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
Int J Nanomedicine; 2019; 14():6497-6517. PubMed ID: 31616141
[TBL] [Abstract][Full Text] [Related]
15. Tumor imaging and interferon-γ-inducible protein-10 gene transfer using a highly efficient transferrin-conjugated liposome system in mice.
Zhuo H; Peng Y; Yao Q; Zhou N; Zhou S; He J; Fang Y; Li X; Jin H; Lu X; Zhao Y
Clin Cancer Res; 2013 Aug; 19(15):4206-17. PubMed ID: 23759675
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo characterization of CPP and transferrin modified liposomes encapsulating pDNA.
Dos Santos Rodrigues B; Kanekiyo T; Singh J
Nanomedicine; 2020 Aug; 28():102225. PubMed ID: 32485318
[TBL] [Abstract][Full Text] [Related]
17. ApoE-2 Brain-Targeted Gene Therapy Through Transferrin and Penetratin Tagged Liposomal Nanoparticles.
Dos Santos Rodrigues B; Kanekiyo T; Singh J
Pharm Res; 2019 Sep; 36(11):161. PubMed ID: 31529284
[TBL] [Abstract][Full Text] [Related]
18. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.
Tang J; Zhang L; Liu Y; Zhang Q; Qin Y; Yin Y; Yuan W; Yang Y; Xie Y; Zhang Z; He Q
Int J Pharm; 2013 Sep; 454(1):31-40. PubMed ID: 23850793
[TBL] [Abstract][Full Text] [Related]
19. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
20. DOPA-based paclitaxel-loaded liposomes with modifications of transferrin and alendronate for bone and myeloma targeting.
Chang Q; Geng R; Wang S; Qu D; Kong X
Drug Deliv; 2016 Nov; 23(9):3629-3638. PubMed ID: 27749106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]